The Christie International (Consulting) team delivers bespoke advice to support healthcare organisations around the world to deliver the best clinical outcomes and experience for their cancer patients. This is often in conjunction with education and training packages, delivered by The Christie Institute of Cancer Education.
Read more about the core team regularly providing advice to these organisations on a commercial basis below.
Other multi-professional experts are available should the advice required fall outside the core team’s expertise.
Please note: The Christie International (Consulting) team does not provide advice directly to patients. International patients, or their representatives, can access information about consultants who provide second medical opinions or treatment via The Christie Private Care or HCA Medical Concierge Service, that supports international patient transfers.
Dr Lee graduated from University of Melbourne, Australia in 1997. From there, he started his general medical training in the UK.
He started working in oncology at The Christie NHS Foundation Trust in 2000 after completing his MRCP. During Dr Lee’s training in oncology at The Christie, he also visited the MD Anderson cancer centre and William Beaumont Hospital in the USA to develop further specific technical skills in intensity modulated radiotherapy (IMRT) and stereotactic ablative radiotherapy (SABR).
Dr Lee is one of the clinical leads who developed stereotactic lung radiotherapy for lung cancer for the first time in the North West. He is currently involved with new developments in IMRT and proton beam therapy for head and neck cancers.
Dr Lee is currently the lead expert clinical advisor on several Christie International projects.
Dr Abdulwahid started working in oncology at The Christie NHS Foundation Trust in 2016, after completing her MD at the University of Buckingham and her MRCP. During her training in oncology at The Christie, she developed technical skills in intensity modulated radiotherapy (IMRT), stereotactic body radiotherapy (SBRT) and proton beam therapy.
Dr Abdulwahid has run training and educational projects for doctors in training at The Christie. She is currently working with a specialist team to expand quality improvement in the Trust and create effective partnership between clinicians and quality improvement staff.
She currently works in the proton beam therapy centre at The Christie and serves as a clinical advisor on several Christie International projects.
Professor Handley began her career in radiotherapy physics in 1990 after completing a PhD in biomedical engineering. She started working at The Christie in 2011 and was appointed Head of the radiotherapy physics group in 2014. In 2024, she stepped back from this role to focus on providing advice on Christie International projects, while still supporting The Christie Physics and Engineering team.
During her time in Manchester, Professor Handley has also played a key role in establishing the cranial stereotactic radiotherapy service at the Salford radiotherapy centre with Salford Royal NHS Foundation Trust (now the Northern Care Alliance). She was heavily involved in the development of the national proton beam therapy (PBT) service and was a contributor to the international MR-Linac consortium.
Professor Handley has a strong background in clinical scientist training in the NHS and is currently programme director of the medical physics theme of a professional doctorate at the University of Manchester.
Dr Mbanu graduated from the University of Liverpool in 2006. He completed his early postgraduate medical training in Liverpool before moving to Manchester for his oncology training.
He began his clinical oncology training at the Christie Hospital in 2013. After completing his oncology training, he undertook a research MD at the University of Manchester, focusing on rectal cancer. His research interest centres on organ preservation in rectal cancer.
Dr Mbanu is the clinical lead for acute oncology services at Salford Royal hospital. This service is provided with the support of acute oncology nurses and other consultant oncologists.
Dr Mbanu serves as a clinical advisor to Christie International (Consulting) projects.
Dr Fatimilehin graduated from Peninsula Medical School in 2014 and began training at The Christie NHS Foundation Trust in 2018. She was appointed consultant clinical oncologist in 2024.
She specialises in paediatric and sarcoma radiotherapy, with technical skills in both photon and proton radiotherapy.
Abiola has worked with the Royal College of Radiologists to help reduce differences in training outcomes among trainees from diverse backgrounds.
In addition to her clinical role, Dr Fatimilehin was appointed staff governor for Registered Medical Practitioners and serves as a clinical advisor to Christie International (Consulting) projects.
Jonathan served 25 years as an Army Officer and worked in both the Ministry of Defence and the Defence Procurement Agency as a senior programme manager procuring defence equipment. He was also selected to attend the Army Staff College and also obtained his MSc in Logistic Management at the Royal Military College of Science. Operational experience included roles in United Nations peace-keeping operations as well as working within other multinational coalitions.
After retiring from the Army, he worked as a commercial manager in a healthcare company before joining the NHS in 2008. He worked as the programme implementation lead for a major reconfiguration of maternity services across Greater Manchester, as well as other major service transformation programmes.
He joined the business development team at The Christie in December 2012 where he was the management lead for the proton beam therapy (PBT) equipment procurement process and established the programme implementation methodology and governance arrangements. He was subsequently appointed as Programme Manager for the Greater Manchester Cancer Vanguard initiative, a 2-year national programme looking at progressing innovations in cancer care.
He is now Head of Christie International and has recently worked on projects in the Republic of Ireland, China and Nigeria.
Sue has over 20 years’ experience managing complex and high-profile projects and international relationships.
Starting her career in the international sports events sector and gaining experience on Commonwealth, Olympic and Paralympic Games as well as Rugby and Netball World Cups, Sue then joined The Christie NHS Foundation Trust in 2015, after moving back home to Greater Manchester.
At The Christie, Sue spent her first 4 years in project management roles within the capital and business development teams. She supported the development of the proton beam therapy centre and Greater Manchester Cancer Vanguard projects.
In 2017, Sue moved into The Christie International team. As international delivery manager, she has successfully delivered a variety of projects for overseas clients. Sue has worked to ensure the advice of Christie’s experts is understood by business managers, as well as clinical and technical specialists.
Sue is a graduate of Oxford University and holds a Prince 2 Practitioner in Project Management qualification.
Zoe has over 25 years’ experience in both clinical and non-clinical NHS roles since qualifying as a therapy radiographer. Her career spans treatment and pre-treatment radiotherapy roles, Macmillan advanced clinical practice roles within patient information, support, and radiotherapy, quality and standards, and leadership roles at both service and directorate level.
Zoe has worked for The Christie NHS Foundation Trust since 2010 holding various positions during this time, all with a focus on patient safety, experience, and support.
Since 2020, Zoe has worked in corporate positions within quality and standards, holding pivotal roles in the Trust’s coordination and incident response to the COVID-19 pandemic and Care Quality Commission activity.
Rachael began her career as a therapeutic radiographer at The Christie where she completed her training and qualified in 2005. Since then, she has held a variety of roles and responsibilities.
Rachael is currently the clinical service manager for radiotherapy at The Christie. In this role, she oversees and strategizes the delivery of advanced radiotherapy treatments, ensuring the highest standards of patient care across all The Christie radiotherapy sites. Her extensive experience includes managing one of The Christie’s radiotherapy centres, and contributing to the establishment and ongoing development of the cranial stereotactic radiotherapy service on The Christie main site as well as at The Christie at Salford.
Most recently, Rachael led the linear accelerator replacement programme at The Christie, managing all aspects from procurement to operational implementation.
